We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alcon Buys Ivantis for $475 Million, Acquiring Glaucoma Surgery Device
Alcon Buys Ivantis for $475 Million, Acquiring Glaucoma Surgery Device
Ophthalmic device company Alcon has completed its $475 million purchase of Ivantis, developer of the Hydrus Microstent, a glaucoma surgery device used to lower eye pressure for open-angle glaucoma patients in connection with cataract surgery.